Relation between plasma and saliva concentrations of enoxacin, ciprofloxacin, and theophylline

Therapeutic Drug Monitoring

Volumn 18, Issue 6, 1996, Pages 666-671

  Zhai, Suoping ^a,b   Wei, Xiaoxiong ^a,b   Parker, Beverly M ^a   Kunze, Kent L ^c   Vestal, Robert E ^a,b,d  

^a Boise VA Medical Center   (United States)

^b IDAHO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Ciprofloxacin; Enoxacin; Plasma; Saliva; Theophylline

Indexed keywords

CIPROFLOXACIN; ENOXACIN; THEOPHYLLINE;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BRONCHODILATATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG MONITORING; DRUG PROTEIN BINDING; DRUG SALIVA LEVEL; FEMALE; HUMAN; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PREDICTION; PRIORITY JOURNAL; RELIABILITY;

ADULT; ANTI-INFECTIVE AGENTS; BRONCHODILATOR AGENTS; CIPROFLOXACIN; DRUG INTERACTIONS; ENOXACIN; FEMALE; HUMANS; MALE; PROTEIN BINDING; SALIVA; THEOPHYLLINE;

EID: 0029807796     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-199612000-00007     Document Type: Article

References (19)

1. Wiinands WJA, Vree TB, van Herwaarden CLA. Enoxacin decreases the clearance of theophylline in man. Br J Clin Pharmacol 1984;20:583-8.
2. Wiinands WJA, Vree TB, van Herwaarden CLA. The influence of quinolone derivatives on theophylline clearance. Br J Clin Pharmacol 1986;22:677-83.
3. Gonzalez MA, Uribe F, Moisen SD, et al. Multiple dose pharmacokinetics and safety of ciprofloxacin in normal volunteers. Antimicrob Agents Chemother 1984;26:741-4.
4. Aronoff GE, Kenner CH, Sloan RS, Pottratz ST. Multiple-dose ciprofloxacin kinetics in normal subjects. Clin Pharmacol Ther 1984;36:384-8.
5. Uematsu M, Morihama T, Sekiguchi T, Imoto T, Sasaki J. Pharmacokinetics and saliva penetration of ofloxacin, norfloxacin, enoxacin and pipemidic acid. Programs and abstracts of the 14th International Congress of Chemotherapy, Kyoto, Japan, 1985.
6. LeBel M, Barbeau G, Bergeron MG, Roy D. Pharmacokinetics of ciprofloxacin in elderly subjects. Pharmacotherapy 1986;6:87-91.
7. Barza M. Pharmacokinetics and efficacy of the new quinolones in infections of the eye, ear, nose, and throat. Rev Infect Dis 1988;10:S241-7.
8. Darouiche R, Perkins B, Musher D, Hamill R, Tsai S. Level of rifampin and ciprofloxacin in nasal secretions: correlation with MIC90 and eradication of nasopharyngeal carriage of bacteria. J Infect Dis 1990;162:1124-7.
9. Koysooko R, Ellis EF, Levy G. Relationship between theophylline concentrations in plasma and saliva of man. Clin Pharmacol Ther 1974;15:454-60.
10. Jonkman JHG, Koeter GH, Schoenmaker R, deVries K, Zeeuw RA. Correlation of serum and saliva theophylline concentration after administration of a sustained release preparation. Eur J Clin Pharmcol 1981;20:73-8.
11. Jaber M, Schneider AT, Goldstein S, Sergiou H, Bjornson L, Chiaramonte LT. Reliability and predictive value of saliva theophylline levels. Ann Allergy 1987;58:105-8.
12. Siegel IA, Ben-Aryeh H, Gozal D, Laufer D. Comparison of unbound and total serum theophylline concentrations with those of stimulated and unstimulated saliva in asthmatic children. Ther Drug Monit 1990;12:460-4.
13. Blanchard J, Harvey S, Morgan WJ. Serum/saliva correlations for theophylline in asthmatics. J Clin Pharmacol 1991; 31:565-70.
14. Blanchard J, Harvey S, Morgan WJ. Relationship between serum and saliva theophylline levels in patients with cystic fibrosis. Ther Drug Monit 1992;14:48-54.
15. Kirk JK, Dupuis RE, Miles MV, Caddy CD, Miranda-Massari JR, Williams DM. Salivary theophylline monitoring: reassessment and clinical consideration. Ther Drug Monit 1994;16:58-66.
16. Kelly HW, Hadley WM, Murphy SA, Skipper BG. Monitoring children on sustained-release therapy by salivary theophylline levels. Am J Dis Child 1981;135:137-9.
17. Rylance GW, Beswick DT, Gullen RE, Roberts DGV. Reevaluation of saliva for monitoring theophylline concentration. Arch Dis Child 1985;60:66-8.
18. Gao Y, Pons G, Rey E, et al. Could saliva stand for plasma in theophylline monitoring in asthmatic children? Still a controversial problem. Fundam Clin Pharmacol 1992;6:191-6.
19. Zhai S, Korrapati MR, Wei X, Muppalla S, Vestal RE. Simultaneous determination of theophylline, enoxacin, and ciprofloxacin in human plasma and saliva by high-performance liquid chromatography. J Chromatogr 1995; 669:372-6.